Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Meridian Bioscience
(NQ:
VIVO
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Jan 30, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Meridian Bioscience
< Previous
1
2
3
4
Next >
Cannabis Stock Gainers And Losers From May 19, 2022
May 19, 2022
GAINERS: Zynerba Pharmaceuticals (NASDAQ:ZYNE) shares closed up 7.42% at $0.99
Via
Benzinga
Marijuana Stock Movers For May 9, 2022
May 09, 2022
GAINERS: Item 9 Labs (OTC:INLB) shares closed up 9.00% at $1.09
Via
Benzinga
Meridian Bioscience's Q2 Revenues Increase 30% To $111M, Highest In Company History
May 06, 2022
Via
Benzinga
Why Meridian Bioscience's Shares Are Rising Today?
February 04, 2022
Meridian Bioscience Inc (NASDAQ: VIVO) has posted
Via
Benzinga
Meridian Bioscience: Q2 Earnings Insights
May 06, 2022
Meridian Bioscience (NASDAQ:VIVO) reported its Q2 earnings results on Friday, May 6, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Earnings Scheduled For May 6, 2022
May 06, 2022
Companies Reporting Before The Bell • Brookfield Renewable (NYSE:BEP) is expected to report quarterly loss at $0.02 per share on revenue of $1.27 billion.
Via
Benzinga
Cannabis Stock Movers For May 5, 2022
May 05, 2022
GAINERS: MGC Pharmaceuticals (OTC:MGCLF) shares closed up 8.62% at $0.01
Via
Benzinga
Meridian Bioscience's Earnings: A Preview
May 05, 2022
Meridian Bioscience (NASDAQ:VIVO) is set to give its latest quarterly earnings report on Friday, 2022-05-06. Here's what investors need to know before the announcement. Analysts estimate that Meridian...
Via
Benzinga
Bullish Sentiment Across The Cannabis Space - Check Full Movers For May 4, 2022
May 04, 2022
GAINERS: Nine Energy Service (NYSE:NINE) shares closed up 15.71% at $3.24
Via
Benzinga
Marijuana Stock Movers For April 26, 2022
April 26, 2022
GAINERS: LOSERS: Leviathan Natural Prods (OTC:LVCNF) shares closed down 13.22% at $0.66
Via
Benzinga
Cannabis Stock Gainers And Losers From April 22, 2022
April 22, 2022
GAINERS: MariMed (OTC:MRMD) shares closed up 5.59% at $0.72
Via
Benzinga
Cannabis Stock Gainers And Losers From April 7, 2022
April 07, 2022
GAINERS: Origin Agritech (NASDAQ:SEED) shares closed up 15.34% at $8.42
Via
Benzinga
Meridian Bioscience Earnings Perspective: Return On Capital Employed
April 01, 2022
According to Benzinga Pro, during Q1, Meridian Bioscience (NASDAQ:VIVO) earned $15.34 million, a 130.43% increase from the preceding quarter. Meridian Bioscience also posted a total of $88.34 million...
Via
Benzinga
Bull of the Day - Meridian Bioscience (VIVO)
March 21, 2022
Meridian Bioscience is a $1 billion provider of diagnostic test kits for gastrointestinal and respiratory infectious diseases.
Via
Talk Markets
Marijuana Stock Movers For March 16, 2022
March 16, 2022
GAINERS: MGC Pharmaceuticals (OTC:
Via
Benzinga
Bullish Tuesday For Marijuana Stocks - Nine Energy Service, ReneSola Among Top Gainers
March 08, 2022
GAINERS: Nine Energy Service (NYSE:
Via
Benzinga
Sail Through the Choppy Market With These 4 Low-Beta Stocks
March 05, 2022
Creating a portfolio of low-beta stocks is important since the securities can deliver healthy returns and provide a shield against volatile market conditions.
Via
Talk Markets
FingerMotion (Nasdaq: FNGR) Looks To Jump On Continued Chinese Smartphone Growth With New Products
February 24, 2022
Photo by 张 嘴 on Unsplash
Via
Benzinga
Boston Scientific Stock Earns Relative Strength Rating Upgrade; Hits Key Threshold
February 23, 2022
A Relative Strength Rating upgrade for Boston Scientific shows improving technical performance.
Via
Investor's Business Daily
Meridian Bioscience: Q1 Earnings Insights
February 04, 2022
Meridian Bioscience (NASDAQ:VIVO) reported its Q1 earnings results on Friday, February 4, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
The Daily Biotech Pulse: Sanofi, Bristol-Myers Squibb Gain On Earnings, Valneva-Pfizer Tout Positive Lyme Disease Vaccine Data, UNITY Biotech Restructures
February 04, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
Earnings Scheduled For February 4, 2022
February 04, 2022
Companies Reporting Before The Bell • Brookfield Business (NYSE:BBU) is estimated to report earnings for its fourth quarter.
Via
Benzinga
Earnings Preview: Meridian Bioscience
February 03, 2022
Meridian Bioscience (NASDAQ:VIVO) is set to give its latest quarterly earnings report on Friday, 2022-02-04. Here's what investors need to know before the announcement. Analysts estimate that Meridian...
Via
Benzinga
Cannabis Stock Gainers And Losers From February 1, 2022
February 01, 2022
GAINERS: MedMen Enterprises (OTC:MMNFF) shares closed up 58.51% at $0.16
Via
Benzinga
Cannabis Stock Gainers And Losers From January 31, 2022
January 31, 2022
GAINERS: Greenlane Hldgs (NASDAQ:GNLN) shares closed up 18.20% at $0.76
Via
Benzinga
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
January 31, 2022
The broader market weakness pervaded into the biotech sector in the week ending Jan. 28, sending stocks lower.
Via
Benzinga
Cannabis Stock Gainers And Losers From January 28, 2022
January 28, 2022
GAINERS: BioHarvest Sciences (OTC:CNVCF) shares closed up 19.61% at $0.33
Via
Benzinga
Meridian Bioscience Inc (VIVO) Q4 2021 Earnings Call Transcript
November 12, 2021
VIVO earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Meridian Bioscience's Q4 Earnings Beat Expectations
November 12, 2021
Meridian Bioscience Inc (NASDAQ: VIVO) posted Q4 sales of $76.2 million, up 19% Y/Y, beating the consensus of $68.40 million. Diagnostics segment net revenues increased...
Via
Benzinga
Topics
Earnings
Exposures
Financial
The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares
November 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus J&J to Separate Its Consumer Health Business Into a New Publicly Traded...
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.